Espec Corp.
Notice on share buyback (Treasury stock acquisition under Article 165, Paragraph 2 of the Companies Act and its Articles of Incorporation)
The acquired shares are 118,400 common shares, total amount 476,349,928 yen, acquisition period from 2026/8/7 to 2026/8/31, method is market purchases. The Board of Directors resolution sets a cap of 1,300,000 shares and 6,000,000,000 yen, with a period from 2026/8/7 to 2027/7/31. The accumulated figures to date fall within this cap.
Key Figures
- 118,400 shares: Total number of shares acquired
- 476,348,992 yen: Total acquisition value
- 1,300,000 shares: Upper limit (as of Board resolution)
- 60 billion yen: Upper limit acquisition value (as of Board resolution)
AI要約
Section Heading
This notice is a disclosure of treasury stock acquisition status based on the provisions of Article 165 and Article 156 of the Companies Act. The type of shares acquired is our ordinary shares, with a cumulative total of 118,400 shares and a total amount of 476,348,992 yen. The acquisition period is from August 7, 2026 to August 31, 2026, and the acquisition method is market purchases. For reference, on August 6, 2026, the Board resolution set an upper limit of 1,300,000 shares (about 6.07% of issued shares) and 60 billion yen, with a period from August 7, 2026 to July 31, 2027; the current cumulative amount is within that upper limit.
Section 2 heading
This treasury stock acquisition is conducted as part of shareholder returns, and it indicates potential additional acquisitions depending on future market conditions and stock price movements. The acquisition period is restricted, and both the cumulative amount and the number of shares are disclosed within the published upper limits, increasing transparency to shareholders. Note that the text does not detail future capital policy directions or intended use of funds, and only reports the progress of the acquisition itself.
Espice Co., Ltd.
Company overview · Stock price · Financial data · All IR
